SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3.91 |
Enterprise Value ($M) | -4.81 |
Book Value ($M) | 4.75 |
Book Value / Share | 3.26 |
Price / Book | 0.82 |
NCAV ($M) | -0.18 |
NCAV / Share | -0.12 |
Price / NCAV | -22.08 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.38 |
Return on Assets (ROA) | -0.97 |
Return on Equity (ROE) | -1.97 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.72 |
Current Ratio | 1.72 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10.66 |
Assets | 15.59 |
Liabilities | 10.84 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -24.60 |
Net Income | -24.13 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -23.79 |
Cash from Investing | 0.00 |
Cash from Financing | 15.60 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Hudson Bay Capital Management LP | 4.99 | -91.81 | |
13G/A | Armistice Capital, Llc | 4.99 | -52.70 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
4,145 | 17,539 | 23.63 | |
4,499 | 27,206 | 16.54 | |
6,915 | 26,376 | 26.22 | |
8,339 | 29,476 | 28.29 | |
(click for more detail) |
Similar Companies | |
---|---|
APM – Aptorum Group Limited | APRE – Aprea Therapeutics, Inc. |
APTO – Aptose Biosciences Inc. | ARTL – Artelo Biosciences, Inc. |
ASNS – Actelis Networks, Inc. |